TIGIT (Mouse): CD155 (Mouse) Homogeneous Assay Kit

Catalog #
78141
$495 *
Size: 384 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The Mouse TIGIT: Mouse CD155 (mTIGIT:mCD155) Homogeneous Assay Kit is designed to measure the inhibition of mTIGIT binding to mCD155. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing mTIGIT and an inhibitor of choice is incubated with the mCD155 for 60 minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

Need us to run inhibitor screens or profile your compounds against TIGIT (Mouse): CD155 (Mouse)? Check out our Immunotherapy Biochemical Screening Services.

Synonyms
T-cell immunoreceptor with Ig and ITIM domains, V-set and immunoglobulin domain-containing protein 9, VSIG9, V-set and transmembrane domain-containing protein 3, VSTM3, PVR, NECL-5, CD155-His
Product Info
Storage and Usage
Citations
Assay Kit Format
AlphaLISA®
Species
Mouse
Supplied As
The mTIGIT:mCD155 Homogeneous Assay Kit comes in a convenient AlphaLISA® format with purified biotinylated Mouse TIGIT, His-tagged Mouse CD155, and assay buffer to perform a total of 384 reactions.
Materials Required But Not Supplied
Name Catalog #
AlphaLISA Ni Chelate Acceptor beads, 5 mg/ml PerkinElmer #AL108C
AlphaScreen Streptavidin-conjugated Donor beads, 5 mg/ml PerkinElmer #6760002S
Optiplate-384 PerkinElmer #6007290
AlphaScreen microplate reader  
Adjustable micropipettor and sterile tips  
Format
Catalog # Name Amount Storage
79269 Mouse TIGIT-Fc-biotin 2x 3 µg -80°C
71167 Mouse CD155-His 2x 5 µg -80°C
79311 3x Immuno Buffer 1 4 ml -20°C
Background

T-cell immunoreceptor with Ig and ITIM domains (TIGIT) is a receptor that is expressed on the surface of T cells and NK cells that binds to CD155 and CD112 on the surface of dendritic cells. Binding of TIGIT with CD155 or CD112 results in inhibition of T cell and NK cell activation. Antibodies and other agents that inhibit this signaling pathway have been shown to increase the immune response, especially in the case of certain cancers.

References

1. Yu, X., et al., Nat. Immunol. 2009; 10(1): 48-57.
2. Stanietsky, N., et al., Proc. Natl. Acad. Sci. 2009; 106(42): 17858-17863.